GSK resolves patent lawsuit against Pfizer over RSV vaccines
By Blake Brittain (Reuters) -British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that ...
McKnight's Long-Term Care News2d
Older adults more apt to receive RSV vaccine, but uptake low in long-term care: study
Older adults and people with certain medical conditions are more likely to receive the respiratory syncytial virus (RSV) ...
Pharmaceutical Technology on MSN2d
Pfizer’s RSV vaccine wins expanded approval in EU, gaining edge over GSK
Abrysvo is now approved in the EU for adults aged 18 to 59 who are at increased risk of lower respiratory tract disease ...
European Commission Approves Pfizer’s RSV Vaccine ABRYSVO® to Help Protect Adults Aged 18-59 Against RSV Lower Respiratory Tract Disease
Pfizer Inc. (NYSE: PFE) announced today that the European Commission (EC) has issued a decision amending the marketing ...
Medscape2d
Kids Are Primary Household Respiratory Syncytial Virus Spreaders
Children aged 6 months to 12 years are the main spreaders of respiratory syncytial virus (RSV) infections within their ...
Val Kilmer died of pneumonia. How does the common illness turn deadly?
The death of actor and leading man Val Kilmer is a stark reminder of how one of the most common lung infections in the ...
Dr. Roach: Reader wonders why symptoms sometimes follow vaccination
The immune system is very good and "wins" most of the time, but you are quite right that symptoms like a low-grade fever, ...
CIDRAP3d
Study underscores risk of death after lower respiratory tract infection
Contracting a non-COVID lower respiratory tract infection raises the risk of death 2 to 7 times over the next month to a year ...
CIDRAP3d
Tests confirm H5N1 avian flu virus in recently recalled raw food for cats
The New York State Department of Agriculture and Markets on March 28 warned consumers about the risk of H5N1 avian flu from ...
Pfizer announces European Commission approval of Abrysvo indication extension
Pfizer (PFE) announced that the European Commission has issued a decision amending the marketing authorization for Abrysvo, the company’s ...
Pharmabiz1d
Pfizer’s RSV vaccine Abrysvo receives European approval to help protect adults aged 18-59 against RSV lower respiratory tract disease
Pfizer’s RSV vaccine Abrysvo receives European approval to help protect adults aged 18-59 against RSV lower respiratory tract disease: New York Wednesday, April 2, 2025, 09:00 H ...